CHARACTERIZATION OF HUMAN OVARIAN SURFACE EPITHELIAL-CELLS IMMORTALIZED BY HUMAN PAPILLOMA VIRAL ONCOGENES (HPV-E6E7 ORFS)

被引:185
作者
TSAO, SW
MOK, SC
FEY, EG
FLETCHER, JA
WAN, TSK
CHEW, EC
MUTO, MG
KNAPP, RC
BERKOWITZ, RS
机构
[1] HARVARD UNIV,SCH MED,DEPT OBSTET GYNECOL & REPROD BIOL,GYNECOL ONCOL LAB,BOSTON,MA 02115
[2] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT PATHOL,BOSTON,MA 02115
[3] UNIV MASSACHUSETTS,MED CTR,WORCESTER,MA 01655
[4] CHINESE UNIV HONG KONG,DEPT ANAT,HONG KONG,HONG KONG
关键词
D O I
10.1006/excr.1995.1184
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Primary human ovarian surface epithelial (HOSE) cells were immortalized by a retroviral vector (LXSN-16E6E7) expressing HPV-E6E7 open reading frames (ORF). Immortalizations of primary ovarian epithelial cells were achieved in three of three attempts. Detailed analysis was carried out in one line, HOSE 6-3, selected on the basis of its epithelial morphology. The immortalized line (HOSE 6-3) was nontumorigenic in nude mice when examined at subculture number 20. Cytogenetic analysis confirmed its human origin and detailed karyotypic analysis revealed a mixed karyotype made up of about 60% of diploid and 40% of near-tetraploid cells. Clonal chromosomal aberration was observed in a subpopulation of cells involving a ring chromosome number 9, Immunofluorescence and two-dimensional gel electrophoresis revealed the presence of vimentin and several species of cytokeratin (K7, K8, K18, K19). The profile of the cytoskeletal filaments of HOSE 6-3 cells is largely identical with that of normal ovarian epithelial cells before immortalization. The immortalized ovarian epithelial cells have a lower sensitivity to TGF-beta 1 inhibition compared to normal ovarian epithelial cells. The immortalized line, HOSE 6-3, has altered growth properties including a higher proliferation rate, plating efficiency, and saturation density. The establishment of a continuous line of human ovarian epithelial cells may provide an in vitro model for study of carcinogenesis in human ovarian cancers. (C) 1995 Academic Press, Inc.
引用
收藏
页码:499 / 507
页数:9
相关论文
共 27 条
[1]   HUMAN PAPILLOMA-VIRUS DNAS IMMORTALIZE NORMAL HUMAN MAMMARY EPITHELIAL-CELLS AND REDUCE THEIR GROWTH-FACTOR REQUIREMENTS [J].
BAND, V ;
ZAJCHOWSKI, D ;
KULESA, V ;
SAGER, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (01) :463-467
[2]   REGULATION OF GROWTH OF NORMAL OVARIAN EPITHELIAL-CELLS AND OVARIAN-CANCER CELL-LINES BY TRANSFORMING GROWTH-FACTOR-BETA [J].
BERCHUCK, A ;
RODRIGUEZ, G ;
OLT, G ;
WHITAKER, R ;
BOENTE, MP ;
ARRICK, BA ;
CLARKEPEARSON, DL ;
BAST, RC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (02) :676-684
[3]   CHROMOSOMAL CHARACTERIZATIONS OF HUMAN NASAL AND NASOPHARYNGEAL CELLS IMMORTALIZED BY HUMAN PAPILLOMAVIRUS TYPE-16 DNA [J].
DEBIECRYCHTER, M ;
ZUKOWSKI, K ;
WANG, CY ;
WEN, WN .
CANCER GENETICS AND CYTOGENETICS, 1991, 52 (01) :51-61
[4]   NUCLEAR MATRIX PROTEINS REFLECT CELL TYPE OF ORIGIN IN CULTURED HUMAN-CELLS [J].
FEY, EG ;
PENMAN, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (01) :121-125
[5]   DIAGNOSTIC RELEVANCE OF CLONAL CYTOGENETIC ABERRATIONS IN MALIGNANT SOFT-TISSUE TUMORS [J].
FLETCHER, JA ;
KOZAKEWICH, HP ;
HOFFER, FA ;
LAGE, JM ;
WEIDNER, N ;
TEPPER, R ;
PINKUS, GS ;
MORTON, CC ;
CORSON, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (07) :436-442
[6]   SPONTANEOUS TRANSFORMATION OF RAT OVARIAN SURFACE EPITHELIAL-CELLS - ASSOCIATION WITH CYTOGENETIC CHANGES AND IMPLICATIONS OF REPEATED OVULATION IN THE ETIOLOGY OF OVARIAN-CANCER [J].
GODWIN, AK ;
TESTA, JR ;
HANDEL, LM ;
LIU, Z ;
VANDERVEER, LA ;
TRACEY, PA ;
HAMILTON, TC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (08) :592-601
[7]  
HALBERT CL, 1990, J VIROL, V65, P473
[8]  
KAIGHN ME, 1989, CANCER RES, V49, P3050
[9]  
KRUK PA, 1990, LAB INVEST, V63, P132
[10]   ALLELE LOSS AT THE RETINOBLASTOMA LOCUS IN HUMAN OVARIAN-CANCER [J].
LI, SB ;
SCHWARTZ, PE ;
LEE, WH ;
YANGFENG, TL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (09) :637-640